AllianceBernstein
GMAB icon

AllianceBernstein’s Genmab GMAB Stock Holding History

AllianceBernstein’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232M Sell
8,644,877
-912,272
-10% -$24.2M 0.08% 180
2026
Q1 		$294M Sell
9,557,149
-1,319,945
-12% -$39.6M 0.1% 164
2025
Q4 		$335M Sell
10,877,094
-76,819
-0.7% -$2.39M 0.11% 152
2025
Q3 		$336M Buy
10,953,913
+291,538
+3% +$7.1M 0.11% 152
2025
Q2 		$220M Sell
10,662,375
-4,062,783
-28% -$83.4M 0.07% 204
2025
Q1 		$288M Sell
14,725,158
-210,066
-1% -$4.41M 0.1% 165
2024
Q4 		$312M Sell
14,935,224
-200,928
-1% -$4.41M 0.11% 149
2024
Q3 		$369M Sell
15,136,152
-101,687
-0.7% -$2.72M 0.12% 136
2024
Q2 		$383M Sell
15,237,839
-16,508
-0.1% -$468K 0.13% 133
2024
Q1 		$456M Sell
15,254,347
-360,163
-2% -$10.6M 0.16% 122
2023
Q4 		$497M Buy
15,614,510
+6,099,301
+64% +$192M 0.19% 101
2023
Q3 		$336M Buy
9,515,209
+1,327,633
+16% +$50.6M 0.14% 134
2023
Q2 		$311M Buy
8,187,576
+1,420,915
+21% +$56.7M 0.13% 150
2023
Q1 		$256M Buy
6,766,661
+431,043
+7% +$16.6M 0.11% 163
2022
Q4 		$269M Buy
6,335,618
+556,129
+10% +$22.9M 0.12% 159
2022
Q3 		$186M Buy
+5,779,489
New +$203M 0.09% 201
2021
Q4 		– Sell
-133,868
Closed -$5.85M – 3314
2021
Q3 		$5.85M Buy
133,868
+7,628
+6% +$342K ﹤0.01% 1524
2021
Q2 		$5.15M Buy
+126,240
New +$4.87M ﹤0.01% 1594
2020
Q4 		– Sell
-309,209
Closed -$11.3M – 3177
2020
Q3 		$11.3M Buy
309,209
+115,218
+59% +$4.17M 0.01% 990
2020
Q2 		$6.57M Buy
+193,991
New +$5.29M ﹤0.01% 1188

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

AllianceBernstein's GMAB Position: Q2 2026 in Review

AllianceBernstein reduced its Genmab (GMAB) stake by 9.5% in Q2 2026, selling an estimated $24.2M and leaving 8,644,877 shares worth $232M. The position accounts for 0.08% of the portfolio, ranked #180.

AllianceBernstein first reported a position in GMAB in Q2 2020 and has held it in 20 quarters since. The position peaked at $497M in Q4 2023. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • AllianceBernstein held 8,644,877 shares of Genmab worth $232M as of Q2 2026.
  • AllianceBernstein sold 912,272 Genmab shares in Q2 2026, an estimated $24.2M.
  • Genmab made up 0.08% of AllianceBernstein's portfolio in Q2 2026, its #180 holding.
  • AllianceBernstein first reported a position in Genmab in Q2 2020 and has held it in 20 quarters since.
  • AllianceBernstein's Genmab position peaked at $497M in Q4 2023.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.